or Try an Advanced Search...

    Benzamides Stocks List

    Symbol Grade Name % Change
    KURA F Kura Oncology, Inc. -36.77
    EVOK F Evoke Pharma, Inc. -1.32
    SNDX F Syndax Pharmaceuticals, Inc. -2.19
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Medicine Cancer Solid Tumors Acute Leukemia Antiemetics Antineoplastic Drugs Blood Cancers Breast Cancer Cancer Cell Cancer Therapies Carcinoma Cell Signaling Chloroarenes Clinical Medicine Diabetes Diabetes Mellitus Disease Gastroenterology Gastrointestinal Gastrointestinal Disorders

    Related ETFs - A few ETFs which own one or more of the above listed Benzamides stocks.

    Symbol Grade Name Weight
    SURI D Simplify Exchange Traded Funds Simplify Propel Opportunities ETF 2.77
    CNCR F Loncar Cancer Immunotherapy ETF 2.5
    SBIO C ALPS Medical Breakthroughs ETF 1.76
    BBC F Virtus LifeSci Biotech Clinical Trials ETF 1.3
    XBI D SPDR S&P Biotech ETF 0.68
    View all Benzamides ETFs...
    Compare ETFs
    Compare CNCR to BBC Compare SURI to CNCR Compare SURI to SBIO

        Benzamides Stocks Recent News

        Date Stock Title
        Nov 21 KURA Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
        Nov 21 KURA Analysts supportive of Kura/Kirin deal despite major selloff (update)
        Nov 21 KURA Kura Oncology: A Contender In The Field Of Precision Medicine
        Nov 21 KURA Kura Oncology Slams The Door On Its Takeover Narrative, And Shares Collapse 26%
        Nov 21 KURA Kura Oncology partners Kyowa Kirin to advance AML treatment
        Nov 20 KURA Kura stock slides 17% on Kyowa Kirin deal for ziftomenib
        Nov 20 KURA Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
        Nov 18 SNDX Syndax secures FDA OK for new kind of leukemia drug
        Nov 18 SNDX FDA approves Syndax’s Revuforj to treat leukaemia
        Nov 15 SNDX Syndax wins FDA approval for leukemia drug revumenib
        Nov 15 SNDX Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Medicine Cancer Solid Tumors Acute Leukemia Antiemetics Antineoplastic Drugs Blood Cancers Breast Cancer Cancer Cell Cancer Therapies Carcinoma Cell Signaling Chloroarenes Clinical Medicine Diabetes Diabetes Mellitus Disease Gastroenterology Gastrointestinal Gastrointestinal Disorders
        Benzamides

        Benzamide is an off-white solid with the chemical formula of C6H5CONH2. It is a derivative of benzoic acid. It is slightly soluble in water, and soluble in many organic solvents.

        More about Benzamides
        Browse All Tags